These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26417609)

  • 1. A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9.
    Yuan M; Gao X; Chard LS; Ali Z; Ahmed J; Li Y; Liu P; Lemoine NR; Wang Y
    Mol Ther Methods Clin Dev; 2015; 2():15035. PubMed ID: 26417609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.
    Jacobs AH; Winkeler A; Hartung M; Slack M; Dittmar C; Kummer C; Knoess C; Galldiks N; Vollmar S; Wienhard K; Heiss WD
    Hum Gene Ther; 2003 Feb; 14(3):277-97. PubMed ID: 12639307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A novel double expression shuttle vector to get marker-free recombinant modified vaccinia virus Ankara].
    Zheng Q; Bi Z; Li M; Hou J; Chen P
    Sheng Wu Gong Cheng Xue Bao; 2011 Jun; 27(6):926-34. PubMed ID: 22034822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selectable and excisable marker system for the rapid creation of recombinant poxviruses.
    Rintoul JL; Wang J; Gammon DB; van Buuren NJ; Garson K; Jardine K; Barry M; Evans DH; Bell JC
    PLoS One; 2011; 6(9):e24643. PubMed ID: 21931792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved safety of a replication-competent poxvirus-based HIV vaccine with the introduction of the HSV-TK/GCV suicide gene system.
    Zhang Q; Liu Z; Hou J; Wang S; Liu C; Wei M; Liu Y; Shao Y
    Vaccine; 2016 Jun; 34(30):3447-53. PubMed ID: 27195760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant loxP vectors for selectable marker recycle and conditional knock-outs.
    Arakawa H; Lodygin D; Buerstedde JM
    BMC Biotechnol; 2001; 1():7. PubMed ID: 11591226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression vector pT7:TKII for the synthesis of authentic biologically active RNA encoding vaccinia virus thymidine kinase.
    Wilson EM; Franke CA; Black ME; Hruby DE
    Gene; 1989 Apr; 77(1):69-78. PubMed ID: 2744489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of Vaccinia Virus Recombinants Using CRISPR/Cas9.
    Gowripalan A; Smith SA; Tscharke DC
    Bio Protoc; 2021 Dec; 11(24):e4270. PubMed ID: 35087929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient auto-excision of a selectable marker gene from transgenic citrus by combining the Cre/loxP system and ipt selection.
    Zou X; Peng A; Xu L; Liu X; Lei T; Yao L; He Y; Chen S
    Plant Cell Rep; 2013 Oct; 32(10):1601-13. PubMed ID: 23771575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic-dependent expression of early transcription factor subunits leads to stringent control of vaccinia virus replication.
    Hagen CJ; Titong A; Sarnoski EA; Verardi PH
    Virus Res; 2014 Mar; 181():43-52. PubMed ID: 24394294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiently editing the vaccinia virus genome by using the CRISPR-Cas9 system.
    Yuan M; Zhang W; Wang J; Al Yaghchi C; Ahmed J; Chard L; Lemoine NR; Wang Y
    J Virol; 2015 May; 89(9):5176-9. PubMed ID: 25741005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposing Roles of Double-Stranded RNA Effector Pathways and Viral Defense Proteins Revealed with CRISPR-Cas9 Knockout Cell Lines and Vaccinia Virus Mutants.
    Liu R; Moss B
    J Virol; 2016 Sep; 90(17):7864-79. PubMed ID: 27334583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient Construction of Large Genomic Deletion in Agrobacterium tumefaciens by Combination of Cre/loxP System and Triple Recombineering.
    Liu Z; Xie Y; Zhang X; Hu X; Li Y; Ding X; Xia L; Hu S
    Curr Microbiol; 2016 Apr; 72(4):465-72. PubMed ID: 26742770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant.
    Puhlmann M; Brown CK; Gnant M; Huang J; Libutti SK; Alexander HR; Bartlett DL
    Cancer Gene Ther; 2000 Jan; 7(1):66-73. PubMed ID: 10678358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNA.
    Weir JP; Bajszár G; Moss B
    Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1210-4. PubMed ID: 6280173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a FLP/frt system for generating helper-dependent adenoviral vectors.
    Ng P; Beauchamp C; Evelegh C; Parks R; Graham FL
    Mol Ther; 2001 May; 3(5 Pt 1):809-15. PubMed ID: 11356086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple-cloning-site plasmids for the rapid construction of recombinant poxviruses.
    Boyle DB; Coupar BE; Both GW
    Gene; 1985; 35(1-2):169-77. PubMed ID: 4029620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A redesigned CRISPR/Cas9 system for marker-free genome editing in Plasmodium falciparum.
    Lu J; Tong Y; Pan J; Yang Y; Liu Q; Tan X; Zhao S; Qin L; Chen X
    Parasit Vectors; 2016 Apr; 9():198. PubMed ID: 27066899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of recombinant fowlpox viruses as vectors for poultry vaccines.
    Boyle DB; Coupar BE
    Virus Res; 1988 Jun; 10(4):343-56. PubMed ID: 2842977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection.
    Vipat S; Brennan G; Park C; Haller SL; Rothenburg S
    J Vis Exp; 2020 May; (159):. PubMed ID: 32510495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.